Vein Illuminator Market Report 2025

The vein illuminator market size has grown exponentially in recent years. It will grow from $28.83 billion in 2024 to $35.12 billion in 2025 at a compound annual growth rate (CAGR) of 21.8%. The growth in the historic period can be attributed to medical imaging advancements, growing number of medical procedures, pediatric and geriatric vein access challenges, focus on patient comfort and safety, emergency and critical care settings, rise in blood donation activities.

The vein illuminator market size is expected to see exponential growth in the next few years. It will grow to $84.72 billion in 2029 at a compound annual growth rate (CAGR) of 24.6%. The growth in the forecast period can be attributed to integration with telemedicine practices, focus on minimally invasive procedures, global health crises preparedness, continued growth in home healthcare, integration with electronic health records. Major trends in the forecast period include technological advancements, integration with mobile technology, enhanced visualization techniques, awareness and training programs, technological innovations in healthcare.

The growth of the vein illuminator market is anticipated to be driven by the increasing incidence of vein diseases. Vein diseases, a common vascular disorder leading to conditions such as varicose veins, often result in elevated vein pressure. Factors such as blood vessel injury from trauma, intravenous catheters, chemotherapeutic agents, infectious organisms, pregnancy, and varicose veins contribute to a higher risk of superficial thrombophlebitis and vein diseases. Healthcare providers require vein illuminators to enhance diagnostic capabilities for identifying and treating these conditions. Notably, the National Library of Medicine reported in August 2022 that approximately $500 million is spent annually on the care of 150,000 patients with chronic venous insufficiency. Moreover, 1% to 2.7% of patients with chronic venous insufficiency are expected to develop venous stasis ulcers, with over 20,000 new cases identified each year.

The growth trajectory of the vein illuminator market is expected to be fueled by the increasing prevalence of chronic diseases. Chronic diseases, characterized by lasting three months or more, often necessitate frequent blood tests and intravenous therapies, posing challenges in locating suitable veins for medical procedures. Vein illuminators play a crucial role in addressing these challenges by improving vein visibility, reducing patient discomfort, and enhancing the overall patient experience. According to the National Center for Biotechnology Information (NCBI), as of January 2023, the global prevalence of chronic diseases is projected to increase to 142.66 million individuals by 2050, compared to 71.522 million in 2020. This rise underscores the significant market demand for vein illuminators.

Technological advancement stands out as a prominent trend gaining traction in the vein illuminator market. Leading companies in the market are directing their focus towards intensive research and development initiatives to drive product innovations, providing enhanced benefits for customers. This commitment to innovation allows companies to secure a competitive edge in the market. An illustrative example is the April 2022 launch by ImmunoTek Bio Centers, a US-based biotech company, introducing VeinViewer technology across its divisions - ImmunoTek Plasma and Freedom Plasma. This technology offers a transparent view of a donor's veins before the needle insertion, facilitating precise blood withdrawal during processes such as plasmapheresis.

Major players in the vein illuminator market are actively developing new vein illuminators based on infrared light technology. Near-infrared light, situated just beyond the visible light spectrum, is characterized by wavelengths slightly longer than those of visible red light. A case in point is the September 2023 launch by PharmEasy, an India-based e-pharmacy company, unveiling the Vein Finder. This innovative device, designed to improve the precision of blood sample collection and enhance patient comfort, utilizes near-infrared light to visualize veins beneath the skin's surface. The handheld Vein Finder addresses the challenge of locating veins, especially in individuals with difficult-to-puncture veins, infants, and the elderly. It significantly improves the success rate of venipuncture, ensuring accurate and swift procedures, thus elevating the overall patient experience. The technology is applicable to patients of all age groups.

In June 2024, Konica Minolta Healthcare Americas, a US-based healthcare company, partnered with Christie Innomed to improve healthcare IT sales and services in the United States. This collaboration seeks to utilize Christie Innomed's well-established Canadian healthcare IT offerings to extend their presence in the U.S. market. Christie Innomed is a Canada-based company that provides vein illuminators.

Major companies operating in the vein illuminator market include AccuVein Inc, CAREstream Group Inc, Infrared Imaging LLC, Near Infrared Imaging Inc, Translite LLC, Venoscope LLC, VueTek Scientific LLC, ZD Medical Inc, Cambridge Medical (Asia) Private Limited, Aimvein Ltd, BK Medical ApS, Shenzhen Bestman Instrument Co, BLZ Medical SAS, RB Healthcare LLC, Vivolight LLC, Christie Medical Holdings Inc, Clear Guide Medical LLC, DRE Medical Inc, InfraRed Imaging Systems Inc, Luminous Medical Inc, Medline Industries Inc, Medtronic plc, Optics Medical LLC, Soma Technology Inc, Spectral Medical Inc, Techno Medica Co.

North America was the largest region in the vein illuminator market in 2024. The regions covered in the vein illuminator market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vein illuminator market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A vein illuminator, also termed vein visualization, is a device leveraging near-infrared (NIR) imaging to detect and map subcutaneous veins, enhancing healthcare providers' vein identification capabilities. These devices employ various techniques for vein visualization.

Key technologies in vein illumination include near-infrared illumination, transillumination, and ultrasound technologies. Near-infrared (NIR) belongs to a segment of the electromagnetic spectrum with wavelengths between 0.7 and 1.4 microns. These technologies find applications in procedures such as intravenous access, blood draws, and other medical interventions. Target end-users encompass hospitals, rehabilitation centers, blood donation camps, and academic institutions.

The vein illuminator market research report is one of a series of new reports that provides vein illuminator market statistics, including vein illuminator industry global market size, regional shares, competitors with a vein illuminator market share, detailed vein illuminator market segments, market trends and opportunities, and any further data you may need to thrive in the vein illuminator industry. This vein illuminator market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vein illuminator consists of sales of vein finders, portable vein viewer detector locators, and vein visualization light devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.